Tag: Martin Shrkeli Scam

Martin Shrkeli’s former drug company goes under
Your take?

Martin Shrkeli’s former drug company goes under

Well, sort of. According to reports, KaloBios Pharmaceuticals has reportedly filed for Chapter 11 bankruptcy listing more than $1.9m in debt and more than $8.1m in assets. Trouble for the company is mounting, considering, Nasdaq informed the company that because of Shrkeli's deceit on the stock market -- they would be delisted come 25 December.
Martin Shrkeli is no longer any kind of pharma CEO
Your take?

Martin Shrkeli is no longer any kind of pharma CEO

And that's at least good news for some. According to several reports, the betrothed  ex-pharma ceo of Turing Pharma (some of which he resigned from Friday) is now no longer working for  KaloBios Pharmaceuticals either. Apparently, Kalobios actually terminated Shrkeli the day of his arrest but never quite announced it to anybody. The decision came after it emerged that Shrkeli had traded stocks illegally on the stock market, and, used funds from one company to pay off another that were earned from the stocks entirely. The company announced Monday that trading had been suspended since last week, and, as of this writing they're unsure when it will resume.  
Internet Villain Martin Shrkeli is planning to hike the price of another drug
Your take?

Internet Villain Martin Shrkeli is planning to hike the price of another drug

SAO PAOLO -- There's trouble in the world of pharmaceuticals once again, and this time, well, they're all accounted back to none other than Martin Shrkeli. According to the New York Times,  Shrkeli has reportedly purchased rights to a premier drug in Latin America used to treat the often fatal disease known as Chagas. The disease, hasn't widely been seen in Northern America since 1955. However, in Latin America the disease is rather prominent and the drug is beneficial to most. As of now, the drug ranges about $50-$100 to retrieve it, however, Shrkeli reportedly plans to raise the praise to nearly $60,000-$100,000. So what's the master plan? As Reuters uncovered, governments give companies making drugs that specifically treat "parasatic diseases" vouchers. These vouchers can later be...
Skip to content